JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

Condition:   Lupus Erythematosus, Systemic Interventions:   Drug: JMKX000189;   Drug: Placebo Sponsor:   Jemincare Recruiting

Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials